About

Watch Longevity is an independent news aggregator covering the peptide therapeutics industry — GLP-1 agonists, amylin analogs, peptide-research drugs, and the regulatory, commercial, and scientific developments shaping the field.

Headlines are crawled every thirty minutes from fifteen primary sources — wire services, regulatory bodies, trade publications, and clinical journals — then editorialized for relevance and category. Stories are selected for clinicians, investors, and operators who need a sharp, daily read on where the field is moving.

We do not write original reporting. Every story links back to its source.